Genetic testing has had a shift in the past ten years, as it has left medical laboratories and entered living rooms.

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it was awarded a multi-year national contract from the United States Department of Veterans ...

Myriad Genetics (MYGN) announced MyRisk Hereditary Cancer Test-the gold standard in germline testing-has been expanded to include genes referenced ...

These genes are strongly associated with cancer risk and may have clear clinical actionability, supporting the goal that each addition to the panel provides meaningful insights for patient care. The ...

SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced MyRisk®Hereditary Cancer Test —the gold ...